Authors:
Sperr, WR
Wimazal, F
Kundi, M
Fonatsch, C
Thalhammer-Scherrer, R
Schernthaner, GH
Schwarzinger, I
Haas, OA
Geissler, K
Lechner, K
Valent, P
Citation: Wr. Sperr et al., Survival analysis and AML development in patients with de novo myelodysplastic syndromes: comparison of six different prognostic scoring systems, ANN HEMATOL, 80(5), 2001, pp. 272-277
Authors:
Sperr, WR
Escribano, L
Jordan, JH
Schernthaner, GH
Kundi, M
Horny, HP
Valent, P
Citation: Wr. Sperr et al., Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis, LEUK RES, 25(7), 2001, pp. 529-536
Authors:
Escribano, L
Diaz-Agustin, B
Bellas, C
Navalon, R
Nunez, R
Sperr, WR
Schernthaner, GH
Valent, P
Orfao, A
Citation: L. Escribano et al., Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis, LEUK RES, 25(7), 2001, pp. 563-570
Authors:
Jordan, JH
Fritsche-Polanz, R
Sperr, WR
Mitterbauer, G
Fodinger, M
Schernthaner, GH
Bankl, HC
Gebhart, W
Chott, A
Lechner, K
Valent, P
Citation: Jh. Jordan et al., A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val, LEUK RES, 25(7), 2001, pp. 627-634
Authors:
Valent, F
Schernthaner, GH
Sperr, WR
Fritsch, G
Agis, H
Willheim, M
Buhring, HJ
Orfao, A
Escribano, L
Citation: F. Valent et al., Variable expression of activation-linked surface antigens on human mast cells in health and disease, IMMUNOL REV, 179, 2001, pp. 74-81
Authors:
Fureder, W
Schernthaner, GH
Ghannadan, M
Hauswirth, A
Sperr, WR
Semper, H
Majlesi, Y
Zwirner, J
Gotze, O
Buhring, HJ
Lechner, K
Valent, P
Citation: W. Fureder et al., Quantitative, phenotypic, and functional evaluation of basophils in myelodysplastic syndromes, EUR J CL IN, 31(10), 2001, pp. 894-901
Authors:
Samorapoompichit, P
Kiener, HP
Schernthaner, GH
Jordan, JH
Agis, H
Wimazal, F
Baghestanian, M
Rezaie-Majd, A
Sperr, WR
Lechner, K
Valent, P
Citation: P. Samorapoompichit et al., Detection of tryptase in cytoplasmic granules of basophils in patients with chronic myeloid leukemia and other myeloid neoplasms, BLOOD, 98(8), 2001, pp. 2580-2583
Authors:
Sperr, WR
Jordan, JH
Baghestanian, M
Kiener, HP
Samorapoompichit, P
Semper, H
Hauswirth, A
Schernthaner, GH
Chott, A
Natter, S
Kraft, D
Valenta, R
Schwartz, LB
Geissler, K
Lechner, K
Valent, P
Citation: Wr. Sperr et al., Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia, BLOOD, 98(7), 2001, pp. 2200-2209
Authors:
Schernthaner, GH
Jordan, JH
Ghannadan, M
Agis, H
Bevec, D
Nunez, R
Escribano, L
Majdic, O
Willhelm, M
Worda, C
Printz, D
Fritsch, G
Lechner, K
Valent, P
Citation: Gh. Schernthaner et al., Expression, epitope analysis, and functional role of the LFA-2 antigen detectable on neoplastic mast cells, BLOOD, 98(13), 2001, pp. 3784-3792
Authors:
Schernthaner, GH
Spanblochl, E
Sperr, WR
Sillaber, C
Semper, H
Jurecka, W
Hagen, M
Wolff, K
Chott, A
Lechner, K
Valent, P
Citation: Gh. Schernthaner et al., Effects of interferon-alpha 2b treatment on ex vivo differentiation of mast cells from circulating progenitor cells in a patient with systemic mastocytosis, ANN HEMATOL, 79(12), 2000, pp. 660-666
Authors:
Wimazal, F
Ghannadan, M
Muller, MR
End, A
Willheim, M
Meidlinger, P
Schernthaner, GH
Jordan, JH
Hager, W
Agis, H
Sperr, WR
Czerwenka, K
Lechner, K
Valent, P
Citation: F. Wimazal et al., Expression of homing receptors and related molecules on human mast cells and basophils: a comparative analysis using multicolor flow cytometry and toluidine blue/immunofluorescence staining techniques, TISSUE ANTI, 54(5), 1999, pp. 499-507